HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroectodermal tumor and monoclonal antibodies.

Abstract
Antibody-producing clones were obtained by hybridization of spleen cells from mice immunized with whole cultured human tumor cells and mouse myeloma cells, P3UX59AG8. The tumor cells were derived from a peripheral primitive neuroectodermal tumor. One of the antibodies produced by these clones reacts with the original cell line, SK-PN-DW, and other more differentiated neuroectodermal tumors such as neuroblastomas and melanomas. The cell line SK-PN-DW contains antigenic determinants recognized by monoclonal antibodies raised against melanoma, neuroblastoma, and human fetal brain. These data indicate that this primitive neuroectodermal tumor is derived from the neuroectoderm.
AuthorsL Helson, C Weinberger, C Helson, P Lieberman
JournalThe American journal of pediatric hematology/oncology (Am J Pediatr Hematol Oncol) Vol. 6 Issue 3 Pg. 227-31 ( 1984) ISSN: 0192-8562 [Print] United States
PMID6097134 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
Topics
  • Adolescent
  • Animals
  • Antibodies, Monoclonal (immunology)
  • Cell Line
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Neoplasms, Germ Cell and Embryonal (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: